Lisa Ingram

Lisa Ingram serves as a key procurement professional within the National Institutes of Health, supporting the strategic acquisition of advanced laboratory instrumentation, biotechnology reagents, and specialized research services critical to advancing biomedical discovery. She manages complex contracting actions for high-precision analytical equipment, clinical research support tools, and technical consulting services that enable hypothesis-driven science and translational research. Her work directly aligns with NIH’s mission to equip federal laboratories with cutting-edge capabilities, ensuring compliance with federal acquisition regulations while prioritizing scientific integrity and operational efficiency. Ingram maintains longstanding relationships with leading contractors including Leidos Biomedical Research Inc., Kelly Services, Inc., and PPD Development LP, partnering with firms that deliver specialized research support, clinical trial management, and laboratory infrastructure services. She frequently engages with vendors offering niche technical expertise in biotechnology R&D, analytical instrument calibration, and scientific data management, favoring established contractors with proven capabilities in federally funded life sciences environments. Her contracting approach emphasizes performance-based outcomes and rigorous vendor evaluation aligned with NIH’s scientific priorities. Her procurement patterns reflect a strong emphasis on open competition, with 65.6% of awards issued without set-aside designations. However, she consistently supports small business participation, allocating 34.4% of contracts to total small business set-asides under FAR 19.5, demonstrating a balanced commitment to both mission-critical scale and socioeconomic goals. While she does not prioritize 8(a), HUBZone, or SDVOSB set-asides, her reliance on small business vendors underscores a pragmatic approach to fostering innovation through diverse supplier engagement. Ingram’s primary procurement focus lies in NAICS 334516 (analytical laboratory instrumentation), 339112 (medical instruments), and 541714 (biotechnology R&D), reflecting deep expertise in procuring mass spectrometers, flow cytometers, sequencing platforms, and specialized bioinformatics services. Her domain knowledge spans laboratory automation, clinical trial logistics, and research infrastructure modernization, positioning her as a strategic partner in enabling NIH’s scientific enterprise.